New Lung Cancer Treatments Aim to Reduce Deaths in 2025 and …
Nov 15, 2024 · For people with later-stage cancers, many new treatment options have been developed. These include new chemotherapy treatments, new targeted therapies that are matched to specific …
Update 2025: Management of Non‑Small-Cell Lung Cancer
Mar 25, 2025 · Since 2024, the non-small-cell lung cancer (NSCLC) landscape has undergone a transformative shift, driven by 11 FDA approvals. Recent advances in molecular profiling, targeted …
NSCLC new treatments: A look at what is coming - labiotech.eu
Apr 30, 2025 · Explore the latest NSCLC new treatments in development, including candidates aimed at tackling hard-to-treat, late-stage lung cancer.
Cancer drug approvals and setbacks in 2025 - Nature
6 days ago · Kelun’s TROP2-targeted sacituzumab tirumotecan (sac-TMT) became the first chemo-free modality to be approved for second line EGFR -mutated NSCLC after tyrosine kinase inhibitor therapy.
New promises and challenges in the treatment of advanced ... - The Lancet
Aug 6, 2024 · Targeted therapies and immunotherapies have radically improved treatment for advanced non-small-cell lung cancer (NSCLC). Tyrosine kinase inhibitors targeting oncogenic driver mutations …
Recent advances in therapeutic strategies for non-small cell lung cancer
Mar 27, 2025 · Both targeted therapy and immunotherapy have significantly improved the survival of patients with metastatic non-small-cell lung cancer (NSCLC). Additionally, recent groundbreaking …
Zongertinib in Previously Treated HER2-Mutant Non–Small-Cell Lung Cancer
Apr 28, 2025 · Innovative oral targeted therapies are warranted for patients with human epidermal growth factor receptor 2 (HER2)–mutant non–small-cell lung cancer (NSCLC).
Clinical Trials Highlight New Treatment Approaches for Lung Cancer ...
May 16, 2025 · Enter aumolertinib, an EGFR-targeted therapy approved in China for the first-line treatment of patients with locally advanced or metastatic NSCLC that harbors an exon 19 deletion or …
Advances in the Treatment of Nonmetastatic Non–Small Cell Lung Cancer ...
May 27, 2025 · As the treatment landscape continues to expand, the prevention and control of adverse events must be prioritized to maximize patient benefit. The NCCN Guidelines for NSCLC reflect the …
How Non-Small Cell Lung Cancer (NSCLC) Treatment Is Improving
Oct 31, 2024 · But progress in treatment options is providing some patients with new avenues, which could eventually change the prognosis for many. Many of the successful therapies for lung cancer …